Carcinoma, Non-Small-Cell Lung × Immunohistochemistry × Clear all Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal Volunteers
Recruiting
700 enrolled
Photodynamic Therapy in Treating Patients With Resectable Non-Small Cell Lung Cancer That Has Spread to the Pleura
Phase 2 Terminated
9 enrolled 5 charts
Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
Phase 1/2 Completed
55 enrolled 11 charts
Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
Phase 1/2 Completed
27 enrolled 7 charts
Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Carboplatin in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung Cancer
Phase 2 Completed
63 enrolled 8 charts
Docetaxel and Bortezomib in Treating Patients With Progressive or Recurrent Non-Small Cell Lung Cancer
Phase 2 Completed
81 enrolled 10 charts
Identifying Biomarkers for Lung Cancer Using Tissue Samples From Patients With Lung Cancer and From Healthy Participants
Completed
689 enrolled
Prognostic Value of PD-L1 in NSCLC
Unknown
350 enrolled
Prognostic Study of Metastases in Patients With Stage I, Stage II, or Stage III Non-small Cell Lung Cancer That Can Be Removed by Surgery
Phase 3 Completed
1,310 enrolled 15 charts
Detection of Early Metastases in Patients With Stage I Non-small Cell Lung Cancer
Completed
501 enrolled
OX-40 Protein Expression in the Sentinel Lymph Nodes of Patients With Cancer
Completed
98 enrolled
Surgery, Gemcitabine, Cisplatin, and Radiation Therapy in Treating Patients With Stage II or Stage III Non-Small Cell Lung Cancer
Phase 2 Terminated
3 enrolled 3 charts
S0424 - Carcinogens in Lung Tissue From Smokers (Closed to Entry as of 7/15/07) and Non-Smokers With Newly Diagnosed Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Completed
981 enrolled
EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer
Phase 2 Completed
60 enrolled
Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer
Phase NA Completed
IRB 2000-294
Completed
200 enrolled
Sorafenib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer That Has Not Responded to Chemotherapy
Phase 2 Unknown
47 enrolled